Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure

American Journal of Cardiology

Volumn 93, Issue 8, 2004, Pages 1007-1011

  Vredevoe, Donna L ^a,b   Widawski, Mel ^a   Fonarow, Gregg C ^a   Hamilton, Michele ^a   Martínez Maza, Otoniel ^a   Gage, Julia R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CELL ASSAY; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CLONAL ANERGY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLYSIS; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MEASUREMENT; MOLECULAR MODEL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STANDARD; SUPERNATANT;

ADULT; AGED; CLONAL ANERGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-6; KILLER CELLS, NATURAL; MALE; MIDDLE AGED;

EID: 1842738677     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.12.054     Document Type: Article

References (33)

1. Woods A., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease the central role of interleukin-6. Eur Heart J. 21:2000;1574-1583.
2. Sharma R., Anker S.D. Immune and neurohormonal pathways in chronic heart failure. Congest Heart Fail. 8:2002;23-28.
3. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 86:1995;1243-1254.
4. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST). Circulation. 103:2001;2055-2059.
5. Baumgarten G., Knuefermann P., Mann D.L. Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc Med. 10:2000;216-223.
6. Torre-Amione G., Kapadia S., Benedict C.R., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1201-1206.
7. Tsutamoto T., Hisanaga T., Wada A., Maeda K., Ohnishi M., Fukai D., Mabuchi N., Sawaki M., Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;391-398.
8. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., Niebauer J., Hooper J., Volk H.D., Coats A.J., Anker S.D. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067.
9. Kägi D., Ledermann B., Bürki K., Zinkernagel R.M., Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 14:1996;207-232.
10. Vredevoe D.L., Moser D.K., Gan X.H., Bonavida B. Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure relationship to norepinephrine. Neuroimmunomodulation. 2:1995;16-24.
11. Futterman A.D., Kemeny M.E., Shapiro D., Fahey J.L. Immunological and physiological changes associated with induced positive and negative mood. Psychosom Med. 56:1994;499-511.
12. Pross H.F., Baines M.G., Rubin P., Shragge P., Patterson M.S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1:1981;51-63.
13. 1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol. 72:1998;3161-3168.
14. Breen E.C., van der Meijden M., Cumberland W., Kishimoto T., Detels R., Martínez-Maza O. The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6. Clin Immunol. 92:1999;293-299.
15. Campbell K.S., Colonna M. Human natural killer cell receptors and signal transduction. Intern Rev Immunol. 20:2001;333-370.
16. Satoskar A.R., Stamm L.M., Zhang X., Okano M., David J.R., Terhorst C., Wang B. NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response. J Immunol. 163:1999;5298-5302.
17. Moretta L., Bottina C., Pende D., Mingari M.C., Biassoni R., Moretta A. Human natural killer cells their origin, receptors and function. Eur J Immunol. 32:2002;1205-1211.
18. Kos F.J. Regulation of adaptive immunity by natural killer cells. Immunol Res. 17:1998;303-312.
19. Stewart S., McIntyre K., Capewell S., McMurray J.J. Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol. 39:2002;760-766.
20. Watson J.M., Sensintaffar J.L., Berek J.S., Martínez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 50:1990;6959-6965.
21. Plante M., Rubin S.C., Wong G.Y., Federici M.G., Finstad C.L., Gastl G.A. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer. 73:1994;1882-1888.
22. Garzetti G.G., Cignitti M., Ciavattini A., Fabris N., Romanini C. Natural killer cell activity and progression-free survival in ovarian cancer. Gynecol Obstet Inves. 35:1993;118-120.
23. Pellicer A., Albert C., Mercader A., Bonilla-Musoles F., Remohi J., Simon C. The follicular and endocrine environments in women with endometriosis local and systemic cytokine production. Fertil Steril. 70:1998;425-431.
24. Provinciali M., Di Stefano G., Muzzioli M., Garzetti G.G., Ciavattini A., Fabris N. Relationship between 17-beta-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis. J Endocrinol Invest. 18:1995;645-652.
25. Ishiyama T., Nakamura S., Akimoto Y., Koike M., Tomoyasu S., Tsuruoka N., Murata Y., Sato T., Wakabayashi Y., Chiba S. Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. Br J Haematol. 86:1994;483-489.
26. Breen E.C., Rezai A.R., Nakajima K., Beall G.N., Mitsuyasu R.T., Hirano T., Kishimoto T., Martínez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol. 144:1990;480-484.
27. Bonavida B., Katz J., Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL2. J Immunol. 137:1986;1157-1163.
28. Zohlnhofer D., Graeve L., Rose-John S., Schooltink H., Dittrich E., Heinrich P.C. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett. 306:1992;219-222.
29. Chen X.P., Losman J.A., Rothman P. SOCS proteins, regulators of intracellular signaling. Immunity. 13:2000;287-290.
30. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 18:2000;143-164.
31. Latchman D.S. Cardiotrophin-1 (CT-1) a novel hypertrophic and cardioprotective agent. Int J Exp Pathol. 80:1999;189-196.
32. Fukuzawa J., Booz G.W., Hunt R.A., Shimizu N., Karoor V., Baker K.M., Dostal D.E. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 an autocrine loop for hypertrophy. Hypertension. 35:2000;1191-1196.
33. Pennica D., King K.L., Shaw K.J., Luis E., Rullamas J., Luoh S.M., Darbonne W.C., Knutzon D.S., Yen R., Chien K.R., et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA. 92:1995;1142-1146.